Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 12;2018(3):27.
doi: 10.21542/gcsp.2018.27.

Neuromuscular diseases with hypertrophic cardiomyopathy

Sergi Cesar  1
Affiliations
Review

Neuromuscular diseases with hypertrophic cardiomyopathy

Sergi Cesar. Glob Cardiol Sci Pract. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Echocardiography from a FA patient with HCM.
The images show an apical 4 chamber with left ventricle HCM (mid-septal and apical regions) and left ventricle short axis image with concentric HCM. The last image shows regional dysfunction and decreased longitudinal strain analyzed with speckle-tracking myocardial strain.
Figure 2.
Figure 2.. FA patient with HCM.
ECG shows LVH data and repolarization abnormalities.
Figure 3.
Figure 3.. Echocardiography of a newborn diagnosed with Barth syndrome.
1) 4 chamber view shows biventricular hypertrophy, 2) shows mixed non-compaction and LV hypertropphy and 3) short axis view shows postero-apical non compaction.
Figure 4.
Figure 4.. Echocardiography from a pediatric Duchenne muscular dystrophy patient.
Note the left ventricle image with slight thickened interventricular septum and heterogeneous echogenicity. The last image shows regional dysfunction and decreased global circumferential strain based on speckle-tracking.
Figure 5.
Figure 5.. BMD patient with cardiomyopathy.
ECG shows LVH data, short PR interval and J point elevation in V2-V4 leads.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Finsterer J, Stöllberger C. Cardiac involvement in primary myopathies. Cardiology. 2000;94:1–11. - PubMed
    1. Coats CJ, Elliott PM. Genetic biomarkers in hypertrophic cardiomyopathy. Biomark Med [Internet] 2013;7(4):505–16. Available from: http://www.futuremedicine.com/doi/10.2217/bmm.13.79 . - PubMed
    1. Task A, Elliott PM, Uk C, Anastasakis A, Germany MAB, Germany MB, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J [Internet] 2014;35(39):2733–79. Available from: https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/... . - PubMed
    1. Scaglia F. Clinical spectrum, and morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics [Internet] 2004;114(4):925–31. Available from: http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2004-0718 . - PubMed
    1. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail. 2010;12(2):114–21. - PubMed

LinkOut - more resources